Government Tender Announcement for Utilizing Medical Information Based on HL7 FHIR Standard

Details

The Pharmaceuticals and Medical Devices Agency (PMDA) has issued a public announcement for a general competitive tender concerning 'Research on Utilizing Medical Information Based on the HL7 FHIR Standard for Drug Safety Measures.' This project aims to leverage standardized data formats, specifically HL7 FHIR, to analyze medical information crucial for ensuring drug safety. The tender was announced on April 16, and the contract period is set from the contract signing date until March 31, 2026. Participation requires meeting strict qualifications, including compliance with relevant budget laws and possessing specific qualification grades (A, B, or C) in the Kanto-Koshinetsu Area for service provision. The tender briefing is scheduled for Wednesday, April 23, 2025, with the submission deadline set for May 27, 2025. This initiative highlights a significant push within Japan's healthcare IT sector to promote data utilization and standardized interoperability using established standards like HL7 FHIR for critical public health functions, such as drug safety monitoring.